Search Results - "Neofytos, Dionysios D"

Synthesis, Kinetic and Conformational Studies of 2-Substituted-5-(β-d-glucopyranosyl)-pyrimidin-4-ones as Potential Inhibitors of Glycogen Phosphorylase by Mavreas, Konstantinos F, Neofytos, Dionysios D, Chrysina, Evangelia D, Venturini, Alessandro, Gimisis, Thanasis

“…Dysregulation of glycogen phosphorylase, an enzyme involved in glucose homeostasis, may lead to a number of pathological states such as type 2 diabetes and…”
Get full text

Formation and physicochemical properties of glycogen phosphorylase in complex with a cationic polyelectrolyte by Neofytos, Dionysios D., Papagiannopoulos, Aristeidis, Chrysina, Evangelia D., Pispas, Stergios

“…The accumulation of rabbit muscle glycogen phosphorylase b (RMGPb) in electrostatic complexes with the cationic polyelectrolyte poly 2-(dimethylamino) ethyl…”
Get full text

A glucose-based molecular rotor inhibitor of glycogen phosphorylase as a probe of cellular enzymatic function by Minadakis, Michail-Panagiotis, Mavreas, Konstantinos F, Neofytos, Dionysios D, Paschou, Maria, Kogkaki, Artemis, Athanasiou, Varvara, Mamais, Michael, Veclani, Daniele, Iatrou, Hermis, Venturini, Alessandro, Chrysina, Evangelia D, Papazafiri, Panagiota, Gimisis, Thanasis

“…Molecular rotors belong to a family of fluorescent compounds characterized as molecular switches, where a fluorescence on/off signal signifies a change in the…”
Get more information

A simple and robust method for laboratory-scale preparation of butter by Gregersen, Sandra Beyer, Boesgaard, Lise Margrethe, Neofytos, Dionysios D., Andersen, Mads Eg, Andersen, Ulf, Corredig, Milena

Get full text

Antimicrobial Prophylaxis and Preemptive Approaches for the Prevention of Infections in the Stem Cell Transplant Recipient, with Analogies to the Hematologic Malignancy Patient by Neofytos, Dionysios, MD, MPH

“…Infectious complications represent one of the most common causes of morbidity and mortality in allogeneic hematopoietic cell transplant (HCT) recipients…”
Get full text

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial by Maertens, Johan A, Prof, Raad, Issam I, Prof, Marr, Kieren A, Prof, Patterson, Thomas F, Prof, Kontoyiannis, Dimitrios P, Prof, Cornely, Oliver A, Prof, Bow, Eric J, Prof, Rahav, Galia, Prof, Neofytos, Dionysios, MD, Aoun, Mickael, MD, Baddley, John W, Prof, Giladi, Michael, MD, Heinz, Werner J, MD, Herbrecht, Raoul, Prof, Hope, William, Prof, Karthaus, Meinolf, Prof, Lee, Dong-Gun, Prof, Lortholary, Olivier, Prof, Morrison, Vicki A, Prof, Oren, Ilana, MD, Selleslag, Dominik, MD, Shoham, Shmuel, MD, Thompson, George R, MD, Lee, Misun, PhD, Maher, Rochelle M, MS, Schmitt-Hoffmann, Anne-Hortense, PhD, Zeiher, Bernhardt, MD, Ullmann, Andrew J, Prof

“…Summary Background Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The SECURE trial assessed efficacy and safety of isavuconazole…”
Get full text

Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT) by Huang, Yao-Ting, PhD, MPH, Foldi, Julia, PhD, Xiao, Kun, MD MPH, Chung, Dick, Neofytos, Dionysios, MD, Kolitsopoulos, Yovanna, BS, Maloy, Molly, MS, Giralt, Sergio, MD, Papadopoulos, Esperanza, MD, Jakubowski, Ann A., PhD, MD, Papanicolaou, Genovefa, MD

Get full text